RHI Entertainment, Opnext: Midday Volume Plays
Several small-cap stocks were moving on above-average volume during Tuesday's session.
12:36PM 11/10/09
Acadia 3Q Loss Narrows On Revenue Boost
Acadia Pharmaceuticals' 3rd-quarter loss narrows on revenue from drug development partners
06:26PM 11/09/09
Mannkind Falls on Talk of Partner, FDA Delay: BioBuzz
Company is delaying partnership talks for inhaled insulin product.
10:18AM 10/06/09
No Lupus Confab Invite for Immunomedics: BioBuzz
Epratuzumab data won't be presented at next week's rheumatology meeting.
07:42AM 10/06/09
Weighing Arena's Obesity Drug: Biotech Mailbag
Readers weigh in on Arena Pharmaceuticals' obesity drug, Affymax's stock, and Cell Therapeutics' pixantrone.
07:00AM 09/04/09
Today's Lists on Stockpickr: Sept. 1
Here's what stood out in the market today.
05:31PM 09/01/09
Bank Of America, MetLife, EBay Are Big Movers
Bank of America, MetLife, EBay, CardioNet are among big market movers Tuesday
05:20PM 09/01/09
Acadia Shares Fall On Failed Parkinson's Study
Acadia Pharmaceuticals shares plunge as Parkinson's disease drug fails late-stage study
11:29AM 09/01/09
Acadia Parkinson's Drug Fails Phase III Study
Pimavanserin doesn't reduce psychosis in Parkinson's patients
06:45AM 09/01/09
Stock Wrap: The Real Story, August 19
Crude oil and energy stocks lead the market higher as the second straight day up helps erase the bad taste of Monday's selloff.
05:17PM 08/19/09
Biotech Calendar: Key Dates and Events
A quick and dirty guide to important biotech events for the busy month of September.
09:00AM 08/18/09
Biotech's Hot and Getting Hotter
July and August are traditionally slow months on the biotech calendar. But not this year as biotech firms, both big and small, release results from clinical trials or await FDA decisions.
08:57AM 08/03/09
Stock Wrap: The Real Story, July 29
The Federal Reserve said the pace of economic decline is slowly moderating, but that did little for investors weary from a drop in oil prices and Chinese stocks Wednesday.
05:13PM 07/29/09
Guests include Marc Lichtenfeld, senior analyst at Mt. Vernon Research, The Street.com's biotech reporter Adam Feuerstein, Breakout Stocks editor Bryan Ashenberg and Patrick Galley, portfolio manager for the RiverNorth Core Opportunity fund.
05:08PM 07/29/09
Acadia Parkinson's Drug May Provide Spark
Acadia Pharmaceuticals could see its stock pop if its drug to treat psychosis related to Parkinson's disease pulls off a resounding clinical trial victory.
11:03AM 07/29/09
Connect with TheStreet